Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-19Clinical Trial Update: Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab with doxorubicin or anti-estrogen therapy in metastatic breast cancer (both triple-negative and hormo…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 [Phase 3]
Phase 3 trial update on Herceptin followed by chemotherapy for metastatic HER2-overexpressing breast cancer; study terminated.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer [Phase 1, Phase 2]
Early-phase trial update on a CEA-targeted CAR-T therapy for relapsed/refractory CEA-positive solid tumors, including lung and colorectal ca…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) [Phase 4]
Open-label Phase 4 neoadjuvant trial update evaluating Ontruzant (SB3) in HER2-positive early breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients [Phase 4]
Phase 4 clinical trial updating on ribociclib efficacy and resistance patterns in advanced breast cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a vaccine therapy with or without Polysaccharide-K in patients with stage IV HER2-positive breast cancer receiv…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer [Phase 4]
Phase 4 clinical trial evaluating immunogenicity response after eribulin treatment in advanced/metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating chidamide in combination with fulvestrant for hormone receptor-positive, HER2-negative advanced breast c…
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: PD-1 Knockout Anti-MUC1 CAR-T Cells in the Treatment of Advanced Breast Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating PD-1 knockout anti-MUC1 CAR-T cells for advanced breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-13Clinical Trial Update: A Study of SHR6390 Combined With Famitinib in the Treatment of HR + / HER2- Advanced Breast Cancer. [Phase 2]
A Phase 2 clinical trial evaluating SHR6390 in combination with famitinib for HR+/HER2- advanced/metastatic breast cancer is underway, with …
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC [Phase 2]
A Phase II trial evaluating camrelizumab in combination with apatinib and eribulin for advanced breast cancer is ongoing; results are not ye…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy [Phase 4]
Phase 4 trial update evaluating selecting the appropriate population for adding a CDK4/6 inhibitor to neoadjuvant endocrine therapy in local…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer [Phase 2, Phase 3]
Phase 2/3 clinical trial update on prehabilitation for women undergoing pre-operative chemotherapy for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer. [Phase 2]
A Phase 2 clinical trial evaluating SHR6390 in combination with anastrozole as preoperative treatment for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs [Phase 2]
Phase II trial evaluating camrelizumab plus apatinib as neoadjuvant therapy for early-stage triple-negative breast cancer with high tumor-in…
-
CLINICAL_TRIALS trial_result · 2023-04-11Clinical Trial Update: Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors [NA]
A completed clinical trial evaluating an alternative exercise program to improve skeletal muscle function and fatigue in breast cancer survi…
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer [Phase 2]
Phase 2 trial of Bintrafusp Alfa in HMGA2-expressing triple-negative breast cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-04-10Clinical Trial Update: Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy [Phase 2]
Phase 2 clinical trial evaluating dalpiciclib plus fulvestrant with pyrotinib for hormone receptor-positive, HER2-low advanced breast cancer…
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating optical surface monitoring technology-guided large-segment radiotherapy for breast cancer is currently…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery [Phase 3]
A Phase 3 trial comparing higher per-day radiation therapy dose versus standard per-day dose in early-stage breast cancer after surgical rem…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer [Phase 2, Phase 3]
A multicenter randomized double-blind Phase II/III trial evaluating GM1 for prevention of peripheral neuropathy induced by albumin-bound pac…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating pyrotinib combined with trastuzumab, dalpiciclib, and letrozole for HR+/HER2+ breast cancer is ongoing w…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer [Phase 2]
Phase 2 study comparing amcenestrant to physician's choice in locally advanced or metastatic estrogen receptor-positive breast cancer. The t…
-
CLINICAL_TRIALS trial_result · 2023-03-30Clinical Trial Update: Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy [Phase 3]
A Phase 3 clinical trial evaluating melatonin supplementation for cancer-related fatigue in patients with breast cancer undergoing radiother…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer [Phase 2]
Phase 2 trial evaluating pegylated liposomal doxorubicin hydrochloride and carboplatin followed by surgery and paclitaxel in triple-negative…